NFKB1 and Alzheimer disease: The researchers concluded that miR-124 controls NF-κB-dependent inflammatory responses in keratinocytes and chronic skin inflammation in AD, suggesting that restoring miR-124 expression may represent a promising therapeutic strategy for AD [59].